| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LRCX | Common Stock | Options Exercise | $0 | +14.5K | +8.84% | $0.00 | 179K | Feb 4, 2025 | Direct | F1, F2 |
| holding | LRCX | Common Stock | 2.37K | Feb 4, 2025 | By 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LRCX | Market-based Performance Restricted Stock Unit | Options Exercise | $0 | -25.5K | -100% | $0.00 | 0 | Feb 4, 2025 | Common Stock | 25.5K | $0.00 | Direct | F3 |
| holding | LRCX | Market-based Performance Restricted Stock Unit | 29.2K | Feb 4, 2025 | Common Stock | 29.2K | $0.00 | Direct | F4 | |||||
| holding | LRCX | Market-based Performance Restricted Stock Unit | 36K | Feb 4, 2025 | Common Stock | 36K | $0.00 | Direct | F5 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 12.3K | Feb 4, 2025 | Common Stock | 12.3K | $59.88 | Direct | F6 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 27.5K | Feb 4, 2025 | Common Stock | 27.5K | $30.03 | Direct | F7 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 23.9K | Feb 4, 2025 | Common Stock | 23.9K | $98.15 | Direct | F8 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 74.3K | Feb 4, 2025 | Common Stock | 74.3K | $17.68 | Direct | F9 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 20.9K | Feb 4, 2025 | Common Stock | 20.9K | $54.06 | Direct | F10 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 29.4K | Feb 4, 2025 | Common Stock | 29.4K | $49.09 | Direct | F11 | |||||
| holding | LRCX | Employee Stock Option (Right to Buy) | 35.8K | Feb 4, 2025 | Common Stock | 35.8K | $19.01 | Direct | F12 |
| Id | Content |
|---|---|
| F1 | On 03/01/2022, the Reporting Person received a target grant of 25,540 Market-based Performance Restricted Stock Units vesting between 0% and 150% on 03/01/2025. The vesting of this award is based on the total return stock price performance of Lam Research shares (assuming reinvestment of dividends) relative to the market price performance of the PHLX Semiconductor Sector Total Return Index, comparing the 50-trading day trailing average closing price over the performance period from 02/01/2022 through 01/31/2025. |
| F2 | The amount reported includes shares subject to unvested restricted stock units. |
| F3 | The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2025. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2022 through 01/31/2025. |
| F4 | The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2027. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2024 through 01/31/2027. |
| F5 | The Market-based performance restricted stock units will vest between 0% and 150% on 03/01/2026. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the PHLX Semiconductor Total Return Index Total Shareholder Return during the performance period of 02/01/2023 through 01/31/2026. |
| F6 | The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024 |
| F7 | The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |
| F8 | The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027. |
| F9 | The stock options will become exercisable in three equal installments on 03/01/2020, 03/01/2021, and 03/01/2022. |
| F10 | The stock options will become exercisable in three equal installments on 03/01/2023, 03/01/2024, and 03/01/2025 |
| F11 | The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026 |
| F12 | The stock options will become exercisable in three equal installments on 03/01/2019, 03/01/2020, and 03/01/2021. |
Adjusted to reflect a ten-for-one forward split of the Issuer's common stock effective after market close on October 2, 2024.